Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04793776 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Manage Emotions to Reduce Aggression (MERA)

Study acronym: MERA
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment closed, study ongoing Final enrollment: 233 participants (planned 204) · Eligibility criteria expanded, about 138 words · Secondary endpoints: details revised at 1 of 1 entry · 2 more Show 5 more changesShow less
    • Final enrollment: 233 participants (planned 204)
    • Eligibility criteria expanded, about 138 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised at 2 of 2 sites
    • Collaborators: details revised at 1 of 5 entries
  2. Primary completion date: Jun 1, 2026 to Oct 1, 2026 Completion date: Jun 30, 2026 to Dec 30, 2026 · Site contacts updated at 1 of 2 sitesv9 Show 2 more changesShow less
    • Completion date: Jun 30, 2026 to Dec 30, 2026
    • Site contacts updated at 1 of 2 sites
  3. Primary completion date: Dec 31, 2025 to Jun 1, 2026v8
  4. 3 versions Re-verified since Dec 16, 2022, no change to tracked fieldsv5-v7
  5. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Oct 1, 2026 to Dec 31, 2025 · Completion date: Mar 1, 2027 to Jun 30, 2026 · Site details revised at 2 of 2 sitesv4 Show 3 more changesShow less
    • Primary completion date: Oct 1, 2026 to Dec 31, 2025
    • Completion date: Mar 1, 2027 to Jun 30, 2026
    • Site details revised at 2 of 2 sites
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Oct 1, 2021 to Jan 3, 2022v3
  2. Primary completion date: Mar 31, 2026 to Oct 1, 2026 Start date: Apr 1, 2021 to Oct 1, 2021 · Completion date: Mar 31, 2026 to Mar 1, 2027v2 Show 2 more changesShow less
    • Start date: Apr 1, 2021 to Oct 1, 2021
    • Completion date: Mar 31, 2026 to Mar 1, 2027
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Post-traumatic stress disorder (PTSD) is one of the most prevalent mental health conditions affecting Veterans who have served since 9/11. Veterans with PTSD report difficulty controlling impulsive aggression (IA). An inability to manage one's emotions (emotion dysregulation) is an underlying mechanism of IA. Reducing IA and increasing use of PTSD evidence-based psychotherapies are two critical missions for the Veterans Health Administration. The proposed research supports these missions by comparing a 3- session emotion regulation treatment (Manage Emotions to Reduce Aggression) to a control group in order to determine if MERA can reduce IA and prepare Veterans for PTSD treatment. By enhancing Veterans' abilities to cope with trauma-related emotions and feel equipped to initiate PTSD treatments, this research aims to help Veterans decrease IA and ultimately recover from PTSD.
Trial Details
NCT Number NCT04793776
Lead Sponsor VA Office of Research and Development
Collaborators: Michael E. DeBakey VA Medical Center, University of South Florida, VA Boston Healthcare System, University of Houston, Texas A&M University
Conditions Stress Disorders, Post-Traumatic, Aggression, Emotion Regulation
Enrollment 233 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov